Hepatology

Liver Tumors

Questions discussed in this category

How do you foresee the integration of artificial intelligence in the management and evaluation of patients with liver lesions/tumors?

1 Answer available

How do you approach treatment options for patients with fibrolamellar HCC compared to "normal" HCC?

1 Answer available

How does the identification of a hepatic adenoma in a male patient affect your management and evaluation?

1 Answer available

How does the use of checkpoint inhibitors for treatment of HCC impact timing of liver transplant and subsequent immunosuppression?

1 Answer available

When would you plan to biopsy a hepatic adenoma to see if it has high risk features/mutations?

1 Answer available

What patient factors impact your selection of initial therapies in patients with localized cholangiocarcinoma?

1 Answer available

What is your evaluation approach for a new patient referral for an incidentally found liver lesion?

1 Answer available

What pre-transplant patient factors impact surveillance intervals and methods after liver transplant for HCC?

1 Answer available

Papers discussed in this category

The American journal of gastroenterology, 2024 Jan 26

ACG Clinical Guideline: Focal Liver Lesions.

The American journal of gastroenterology, 2024 Oct 21

Focal Liver Lesions.

JAMA oncology, 2017-04-01

Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2018-05

Validation of the prognostic power of the RETREAT score for hepatocellular carcinoma recurrence using the UNOS database.

Transplant international : official journal of the European Society for Organ Transplantation, 2021 Nov 22

The RETREAT score provides valid predictions regarding hepatocellular carcinoma recurrence after liver transplantation.

Related Topics in Hepatology